The Study of Anti-CD19 CAR NK Cells in the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma
NCT05673447
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Diffuse Large B Cell Lymphoma
Interventions
BIOLOGICAL:
anti-CD19 CAR NK cells
Sponsor
Changhai Hospital
Collaborators
[object Object]